Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Rebif approval application
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Differential transcriptional response profiles in human myeloid cell populations.
Overview of the immune system.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Timing of birth and risk of multiple sclerosis: population based study.
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA TM*) in Multiple Sclerosis
Multiple Sclerosis Society Education Conference
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.

Pages